OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Umar Mehraj, Umar Mushtaq, Manzoor Ahmad Mir, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 769-783
Closed Access | Times Cited: 63
Umar Mehraj, Umar Mushtaq, Manzoor Ahmad Mir, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 769-783
Closed Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
Shazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Open Access | Times Cited: 89
Shazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Open Access | Times Cited: 89
Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: A comprehensive analysis
Umar Mehraj, Shariqa Aisha, Shazia Sofi, et al.
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100037-100037
Open Access | Times Cited: 57
Umar Mehraj, Shariqa Aisha, Shazia Sofi, et al.
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100037-100037
Open Access | Times Cited: 57
Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis
Hina Qayoom, Shazia Sofi, Manzoor Ahmad Mir
Immunologic Research (2023) Vol. 71, Iss. 4, pp. 588-599
Closed Access | Times Cited: 40
Hina Qayoom, Shazia Sofi, Manzoor Ahmad Mir
Immunologic Research (2023) Vol. 71, Iss. 4, pp. 588-599
Closed Access | Times Cited: 40
Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation
Shazia Sofi, Nusrat Jan, Hina Qayoom, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 9, pp. 103774-103774
Open Access | Times Cited: 25
Shazia Sofi, Nusrat Jan, Hina Qayoom, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 9, pp. 103774-103774
Open Access | Times Cited: 25
PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer
Qianzhi Chen, Qingyi Hu, Yan Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 25
Qianzhi Chen, Qingyi Hu, Yan Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 25
Study of Iron Complex Photosensitizer with Hollow Double‐Shell Nano Structure Used to Enhance Ferroptosis and Photodynamic Therapy
Xinrui Cai, Weixing Liu, Jiahao Zhang, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 10
Xinrui Cai, Weixing Liu, Jiahao Zhang, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 10
Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis
Umar Mehraj, Bader Alshehri, Azmat Ali Khan, et al.
Clinical Breast Cancer (2022) Vol. 22, Iss. 6, pp. 567-578
Closed Access | Times Cited: 34
Umar Mehraj, Bader Alshehri, Azmat Ali Khan, et al.
Clinical Breast Cancer (2022) Vol. 22, Iss. 6, pp. 567-578
Closed Access | Times Cited: 34
Identification and analysis of dysregulated fatty acid metabolism genes in breast cancer subtypes
Umar Yousuf, Shazia Sofi, Aanisa Makhdoomi, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 31
Umar Yousuf, Shazia Sofi, Aanisa Makhdoomi, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 31
Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study
Hina Qayoom, Umar Mehraj, Shazia Sofi, et al.
Medical Oncology (2022) Vol. 39, Iss. 10
Closed Access | Times Cited: 30
Hina Qayoom, Umar Mehraj, Shazia Sofi, et al.
Medical Oncology (2022) Vol. 39, Iss. 10
Closed Access | Times Cited: 30
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation
Hina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 7, pp. 103705-103705
Open Access | Times Cited: 20
Hina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 7, pp. 103705-103705
Open Access | Times Cited: 20
Involvement of ACACA (acetyl-CoA carboxylase α) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts
Yung‐Chi Huang, Ming‐Feng Hou, Ying‐Ming Tsai, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 643-660
Open Access | Times Cited: 19
Yung‐Chi Huang, Ming‐Feng Hou, Ying‐Ming Tsai, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 643-660
Open Access | Times Cited: 19
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
Umar Mehraj, Nissar Ahmad Wani, Abid Hamid, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Umar Mehraj, Nissar Ahmad Wani, Abid Hamid, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt/ERK/NF-κB signaling
Sujian Xiao, Tong Yu, Fulan Yang, et al.
Biochemistry and Cell Biology (2025)
Closed Access
Sujian Xiao, Tong Yu, Fulan Yang, et al.
Biochemistry and Cell Biology (2025)
Closed Access
TNIP1 Impacts Prognosis by Modulating the Immune Microenvironment in BRCA
Dong Liao, Wu Liu, Yunhui Jiang, et al.
Biochemical Genetics (2025)
Closed Access
Dong Liao, Wu Liu, Yunhui Jiang, et al.
Biochemical Genetics (2025)
Closed Access
Implantable Polymer Scaffolds Loaded with Paclitaxel–Cyclodextrin Complexes for Post-Breast Cancer Tissue Reconstruction
Liliana-Roxana Balahura, Andreea I. Dinu, Adriana Lungu, et al.
Polymers (2025) Vol. 17, Iss. 3, pp. 402-402
Open Access
Liliana-Roxana Balahura, Andreea I. Dinu, Adriana Lungu, et al.
Polymers (2025) Vol. 17, Iss. 3, pp. 402-402
Open Access
Discovery of Naphthoquinone-Furo-Piperidone Derivatives as Dual Targeting Agents of STAT3 and NQO1 for the Treatment of Breast Cancer
Shengying Lou, Chenjun Shen, Hao Ni, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117377-117377
Closed Access
Shengying Lou, Chenjun Shen, Hao Ni, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117377-117377
Closed Access
Identification of Genes and Pathways Involved in Breast Cancer Subtypes through Expression Meta-analysis
Mandana Kazemi, Mandana Kazemi, Mehrdad Behmanesh, et al.
Indian Journal of Clinical Biochemistry (2025)
Closed Access
Mandana Kazemi, Mandana Kazemi, Mehrdad Behmanesh, et al.
Indian Journal of Clinical Biochemistry (2025)
Closed Access
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential
Yongcheng Su, Qingquan Bai, Wenqing Zhang, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 454-454
Open Access
Yongcheng Su, Qingquan Bai, Wenqing Zhang, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 454-454
Open Access
Fundamental knowledge and research regarding the role of immunity in triple-negative breast cancer from 2014–2024: A bibliometric analysis
Xudong Li, Chun Lou, He Ren, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Xudong Li, Chun Lou, He Ren, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Liquid-based biomarkers in breast cancer: looking beyond the blood
You Shuai, Zhonghua Ma, Jie Ju, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
You Shuai, Zhonghua Ma, Jie Ju, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Breast cancer and its therapeutic targets: A comprehensive review
Ayushi Singh, Rakhi Mishra, Avijit Mazumder
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 8
Ayushi Singh, Rakhi Mishra, Avijit Mazumder
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 8
Chemokines and receptors in the development and progression of malignant tumors
Hanqing Zhao, Jun Jiang
Cytokine (2023) Vol. 170, pp. 156335-156335
Closed Access | Times Cited: 7
Hanqing Zhao, Jun Jiang
Cytokine (2023) Vol. 170, pp. 156335-156335
Closed Access | Times Cited: 7
Role of regulatory T cells in cancer
Manzoor Ahmad Mir, Abrar Yousuf Mir
Elsevier eBooks (2022), pp. 113-136
Closed Access | Times Cited: 11
Manzoor Ahmad Mir, Abrar Yousuf Mir
Elsevier eBooks (2022), pp. 113-136
Closed Access | Times Cited: 11
MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells
Jili Hu, Wang Jia, Xu Guo, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29210-e29210
Open Access | Times Cited: 2
Jili Hu, Wang Jia, Xu Guo, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29210-e29210
Open Access | Times Cited: 2
Platelet Membrane-Camouflaged Silver Metal–Organic Framework Biomimetic Nanoparticles for the Treatment of Triple-Negative Breast Cancer
Haiting Liu, Guangqing Cai, Shuai Yuan, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3577-3590
Closed Access | Times Cited: 2
Haiting Liu, Guangqing Cai, Shuai Yuan, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3577-3590
Closed Access | Times Cited: 2
